Filter Results:
(628)
Show Results For
- All HBS Web
(1,051)
- People (3)
- News (261)
- Research (628)
- Events (1)
- Multimedia (6)
- Faculty Publications (295)
Show Results For
- All HBS Web
(1,051)
- People (3)
- News (261)
- Research (628)
- Events (1)
- Multimedia (6)
- Faculty Publications (295)
Sort by
- 13 Feb 2013
- Research & Ideas
5 Weight Loss Tips From Behavioral Economists
Weight Loss: A Randomized, Controlled Trial," published in the June 2011 edition of Journal of General Internal Medicine. TIP #3- Fill your backpack with rocks. A research team from Harvard and the University of Central Florida View Details
Keywords: by Carmen Nobel
- 28 Nov 2016
- Research & Ideas
Challenging the Belief that Liability Laws Kill Medical Device Innovation
Doctors are afraid of getting sued. According to some accounts, 75 percent of them perform more tests and procedures than necessary to avoid potential lawsuits over medical malpractice. The phenomenon of... View Details
- November 2007
- Case
Antegren: A Beacon of Hope
By: Joshua D. Margolis, Thomas J. DeLong and Terence Heymann
The CEO of Biogen Idec faces a set of difficult decisions regarding a promising drug for Multiple Sclerosis that is headed for early approval by the FDA. The first in a series focuses on operational decisions triggered by the drive for early approval. Sparks discussion... View Details
Keywords: Demand and Consumers; Leadership; Ethics; Corporate Social Responsibility and Impact; Decision Choices and Conditions; Crisis Management; Health Testing and Trials; Biotechnology Industry; Pharmaceutical Industry
Margolis, Joshua D., Thomas J. DeLong, and Terence Heymann. "Antegren: A Beacon of Hope." Harvard Business School Case 408-025, November 2007.
- 28 Nov 2011
- Research & Ideas
Rethinking the Fairness of Organ Transplants
distribution of recipients across different groups by age, race, diagnosis, and blood type. "This gives policymakers the ability to focus on what's important and relevant," he adds. "Right... View Details
- 18 Jun 2014
- Research & Ideas
Book Excerpt: ‘Collective Genius’
long as possible because they know fruitful integration can occur only after people have devoted sufficient time to debating options or testing them through trial and error.... View Details
- June 2004 (Revised November 2004)
- Case
Acorda Therapeutics: Rebuilding the Spinal Cord
Acorda is an early-stage life science start-up with a promising product that is close to reaching the market (Phase III clinical trials). The company is grappling with how to expand its portfolio of molecules to make the business more sustainable. It faces classic... View Details
Keywords: Decision Making; Science-Based Business; Health Testing and Trials; Business Startups; Product Development; Biotechnology Industry
Enriquez-Cabot, Juan, Jonathan West, Marina Kolesnik, and Fiona Murray. "Acorda Therapeutics: Rebuilding the Spinal Cord." Harvard Business School Case 604-014, June 2004. (Revised November 2004.)
- 11 Aug 2014
- HBS Case
The Business of Behavioral Economics
of these principles with individuals, can they be used by companies to help employees meet their health and other goals? Norton has been experimenting with one behavioral economic principle—social norming—in... View Details
- May 1999 (Revised July 2000)
- Teaching Note
Reading Rehabilitation Hospital: Implementing Patient-Focused Care TN
By: Jody H. Gittell and Sandra J. Sucher
Teaching Note for (9-898-172). A rewritten version of an earlier teaching note. View Details
- 27 May 2020
- Research & Ideas
What South Korea Teaches the World About Fighting COVID
whereas South Korea has 216 cases per million. "South Korea created a vast number of testing sites, which included not only big hospitals but local clinics and public health... View Details
- September 2020
- Case
Merck: COVID-19 Vaccines
By: Willy C. Shih
COVID-19 infections were still climbing across the U.S. and many other parts of the world in September 2020, and it seemed that every time Ken Frazier, the CEO of Merck & Co. consented to an interview in recent months he always seemed to hear the same question,... View Details
Keywords: Vaccines; COVID-19 Pandemic; Health Pandemics; Health Testing and Trials; Innovation and Management; Innovation Strategy; Technological Innovation; Business Strategy; Product Launch; Pharmaceutical Industry
Shih, Willy C. "Merck: COVID-19 Vaccines." Harvard Business School Case 621-028, September 2020.
- 13 Aug 2018
- Research & Ideas
Women Heart Patients Have Better Survival Odds with Women Doctors
heart attack. Of those, between 1,500 to 3,000 fewer women may have died if their doctor had been female, Laura Huang, a study co-author and Harvard Business School associate professor, said in an interview. The research mirrors bias... View Details
- 14 Apr 2021
- Research & Ideas
The High Cost of the Slow COVID Vaccine Rollout
dollars in value, Kominers and his co-authors reported in Market Design to Accelerate COVID-19 Vaccine Supply in the March 12 issue of Science. “The value of being able to produce vaccines at scale the minute they clear View Details
- 02 Jun 2011
- Research & Ideas
Signing at the Top: The Key to Preventing Tax Fraud?
end of the tax form, after the form has been filled out and, consequently, after the potential cheating has occurred. (It's analogous to a witness first testifying in a court trial and then swearing on a... View Details
- 20 Sep 2011
- First Look
First Look: September 20
team's knowledge-integration capability. We test our theoretical framework using data on knowledge workers in professional services and discuss implications for research and... View Details
Keywords: Sean Silverthorne
- June 2007
- Article
Efficient Kidney Exchange: Coincidence of Wants in a Structured Market
By: A. E. Roth, Tayfun Sonmez and M. Utku Unver
Patients needing kidney transplants may have donors who cannot donate to them because of blood or tissue incompatibility. Incompatible patient-donor pairs can exchange donor kidneys with other pairs only when there is a "double coincidence of wants." Developing... View Details
Keywords: Organizational Structure; Size; Emotions; Human Needs; Health Care and Treatment; Health Testing and Trials; Infrastructure; Supply Chain Management; Fairness; Performance Improvement; Health Industry
Roth, A. E., Tayfun Sonmez, and M. Utku Unver. "Efficient Kidney Exchange: Coincidence of Wants in a Structured Market." American Economic Review 97, no. 3 (June 2007): 828–851.
- 10 Oct 2000
- Research & Ideas
Cross-Sector Collaboration: Lessons from the International Trachoma Initiative
The aim, write the authors, is "to deepen our understanding of the process of cross-sector collaboration in the public health arena and the factors contributing to effective partnering." They begin... View Details
- 28 Jul 2016
- Op-Ed
Where is TripAdvisor for Doctors?
review sites for family doctors, pediatricians, heart surgeons, psychiatrists and others involved in health care delivery? There are seven key barriers. Some can be overcome by a cleverly designed website,... View Details
- 17 Feb 2016
- Research & Ideas
Man vs. Machine: Which Makes Better Hires?
who has studied how companies make organizational decisions in industries such as health care and education. “They are figuring out how to use the information of managers and... View Details
- January 2017
- Supplement
Terrapin Laboratory: Exercise
By: Joseph B. Fuller and Christopher Payton
In this exercise, we examine the capital requirements of Terrapin Laboratory as they contemplate entering into a new market segment. The company is faced with two potential financing options which have different effects on the ownership structure of the company.... View Details
- 18 Jul 2018
- Research & Ideas
No More General Tso's? A Threat to 'Knowledge Recombination'
Cohly was skilled in Ayurveda, the ancient Indian practice of herbal medicine, and suggested they try using turmeric to heal the wound instead. The spice worked, and Das and... View Details